News | News By Subject | News by Disease News By Date | Search News

Meningitis, bacterial News Articles

Get Our FREE
Industry eNewsletter
Top Breaking News
GlaxoSmithKline (GSK) Divests Two Meningitis Drugs to Pfizer (PFE) for $130 Million     6/23/2015
AmerisourceBergen Corporation (ABC) the “Pony to Ride” for Biosimilar Opportunities, Says UBS     3/16/2015
Analyst: Current Crop of Biotech IPOs a Mixed Bag of Low Market Caps, Little Data     12/3/2014
Best Value In Biotech? Actavis (ACT), Says UBS     11/17/2014
Pfizer Inc. (PFE) Touts Phase 2 Data For Investigational Meningococcal B Vaccine     5/9/2014
FDA Grants Breakthrough Status Designation To Novartis AG (NVS)' Meningitis B Vaccine     4/8/2014
Pfizer Inc. (PFE)'s Meningitis Vaccine Wins Breakthrough Status From The FDA     3/20/2014
Novartis AG (NVS) Starts Supplying Meningitis B Vaccine To Princeton University     12/9/2013
Princeton University Unlikely To Face Liability Over Novartis AG (NVS) Vaccine     12/2/2013
FDA Expands Age Indication for Novartis AG (NVS)'s Menveo®, First and Only Quadrivalent Meningococcal Vaccine for Infants as Young as 2 Months of Age[1]     8/2/2013
FDA Approves GlaxoSmithKline (GSK) Drug for Treatment of Anthrax     12/18/2012
Novartis AG (NVS) Bexsero Meningitis Shot Wins EU Agency's Backing     11/16/2012
FDA: New England Compound Center Drugs Tied to Meningitis     10/8/2012
Novartis AG (NVS) Banks on Meningitis Shot to Justify "Oops" Deal; Restructuring, Disposal a Possibility: Analyst     10/1/2012
Novartis AG Vaccine Shields Against Meningitis Cause     6/9/2011

News from Around the Web
Man Tied To Deadly 2012 Meningitis Outbreak Pleads Not Guilty     9/12/2014
Nasal Spray Vaccine for Meningitis In Pipeline, University of Liverpool Study     7/27/2010
Break Through In The Treatment Of Bacterial Meningitis, University of Nottingham Study     5/13/2009
US Centers for Disease Control and Prevention (CDC) Warns Of Uptick In Meningitis In Kids     1/26/2009
Meningitis Vaccine Seems to Work Like a Charm, University of Pittsburgh School of Medicine Study     1/15/2009
Partial Vaccine Dose May Work As Well As Full Shot, EPICENTRE Biotechnologies Study     12/2/2008
Panel Hesitates On Expanding Meningitis Shots     2/28/2008
FDA Urges Meningitis Vaccination for Patients with Cochlear Implants     10/11/2007
New Meningitis Vaccine May End Epidemics     6/11/2007
Vaccine Blocks Deadly Form of Meningitis     6/8/2007
New Low-Cost Vaccine for Africa by GlaxoSmithKline (GSK)(Jobs)     3/30/2007
Meningitis 'Reduces Exam Success'     3/22/2007
FDA Set to Approve Controversial Cow Drug: Could Hurt Human Health     3/5/2007
Clinical Guidelines Help Identify Which Children At Risk Of Bacterial Meningitis     1/3/2007
Officials Say Meningitis Vaccine Shortfall Is Over     11/3/2006

Press Releases
Pfizer (PFE) Announces European Medicines Agency Acceptance For Review Of Marketing Authorization Application For TRUMENBA (Meningococcal Group B Vaccine)     5/20/2016
U.S. CDC Recommends Cautious Approach To GlaxoSmithKline (GSK), Pfizer (PFE) Meningitis B Vaccine     6/25/2015
Recent Cases Of Meningococcal Disease On College Campuses Reinforce Need For Education About Prevention - A Statement From The National Meningitis Association     2/10/2015
Health Canada Approves Novartis Pharmaceuticals Canada Inc. (NVS)'s Bexsero*, The First Vaccine Available To Prevent Meningococcal Serogroup B (MenB)(1,2)     12/9/2013
GlaxoSmithKline (GSK) Files Meningococcal Conjugate Vaccine     3/30/2007
BioVeris Corporation (BIOV) Completes New Vaccine License     12/27/2006
Sanofi Pasteur (SASY.PA) Seeks To Broaden Age Group For New Vaccine To Protect Against Meningococcal Disease     3/17/2005
BioVeris (BIOV) Completes Agreements With Children's Hospital & Research Center At Oakland     1/13/2005
Shire Pharmaceuticals Group PLC (SHPGY) Release: Health Canada Approves A New Two-Dose Regimen Of NeisVac-C To Protect Against MeningitiS C - Reducing Vaccination Burden In Infants     5/5/2004
Affymetrix (Santa Clara, California) (AFFX) Resequencing Array Classifies Previously Nontypeable Meningitis Strains In Study By UK Health Protection Agency     4/6/2004